Answers are grounded in this paper and cite their sources.
Procedures have now been developed for inserting functional genes into the bone marrow of mice. The most effective delivery system at present uses retroviral-based vectors to transfer a gene into murine bone marrow cells in culture. The genetically altered bone marrow is then implanted into recipient animals. These somatic cell gene therapy techniques are becoming increasingly efficient. Their future application in humans should result in at least partial correction of a number of genetic disorders. However, the safety of the procedures must still be established by further animal studies before human clinical trials would be ethical.
No takes yet. Share an insight, caveat, or question.
W. French Anderson (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: